PDCD1 and non-small cell lung carcinoma: The existence of these enterococcal bacteriophages in stools along with the tumor expression of TMP-cross-reactive epitopes was associated with increased overall survival in NSCLC and RCC patients subjected to anti-PD1 therapy [20].